Submitted by Anonymous (not verified) on 8 September 2023 - 9:59
Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 13/05/2022, Revision: 4, Status: Authorised
Source: